alogliptin and metformin hydrochloride

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 45802-211
  • Package NDC 45802-211-72
  • Application number NDA203414
  • SPL ID eb8e70d9-7ea0-4154-99b6-07e7ba15fe14
  • SPL set ID 14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba
  • UNII 786Z46389E
  • UNII EEN99869SC
  • RxCUI 1368385
  • RxCUI 1368392

What the source publishes

Labeler
Padagis Israel Pharmaceuticals Ltd
Active ingredients
alogliptin and metformin hydrochloride
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA AUTHORIZED GENERIC
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:45802-211_eb8e70d9-7ea0-4154-99b6-07e7ba15fe14
{
  "name": "alogliptin and metformin hydrochloride",
  "splId": "eb8e70d9-7ea0-4154-99b6-07e7ba15fe14",
  "labels": [
    {
      "setId": "14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Padagis Israel Pharmaceuticals Ltd",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "60 TABLET, FILM COATED in 1 BOTTLE (45802-211-72)",
      "package_ndc": "45802-211-72",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20160408"
    }
  ],
  "productId": "45802-211_eb8e70d9-7ea0-4154-99b6-07e7ba15fe14",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "45802-211",
  "deaSchedule": null,
  "genericName": "alogliptin and metformin hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ALOGLIPTIN BENZOATE",
      "strength": "12.5 mg/1"
    },
    {
      "name": "METFORMIN HYDROCHLORIDE",
      "strength": "1000 mg/1"
    }
  ],
  "applicationNumber": "NDA203414",
  "marketingCategory": "NDA AUTHORIZED GENERIC",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20160408",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0345802169723",
      "0345802211729"
    ],
    "unii": [
      "786Z46389E",
      "EEN99869SC"
    ],
    "rxcui": [
      "1368385",
      "1368392"
    ],
    "spl_set_id": [
      "14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba"
    ],
    "manufacturer_name": [
      "Padagis Israel Pharmaceuticals Ltd"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:45802-211_eb8e70d9-7ea0-4154-99b6-07e7ba15fe14"